|
National Stock Number(NSN): 6505-01-338-4709 (6505013384709, 013384709)
| NIIN: |
01-338-4709 |
Item Name: |
INSULIN HUMAN ISOPHANE SUSPENSION AND INSULIN HUMAN INJECTION |
INC: |
77777 |
| FSC: |
6505
|
Assignment Date: |
May-04-1991 |
CRIT: |
N |
IIG: |
77777 |
| ISC: |
2 |
Date Standardized: |
May-04-1991 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
May-01-2004 |
PMIC: |
A |
FIIG: |
A23900 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
1 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
91-0175 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00003-1837-15 |
60554
|
NOVO NORDISK INC |
H |
5 |
9 |
4 |
KX |
|
|
|
|
|
|
|
NDC00003-1837-17 |
60554
|
NOVO NORDISK INC |
H |
5 |
9 |
4 |
KX |
|
B |
|
|
|
|
|
NDC00169-1837-17 |
60554
|
NOVO NORDISK INC |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NOVOLIN 70/30 PENFILL |
60554
|
NOVO NORDISK INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
M |
U |
1 |
A |
$12.67 |
PG |
|
C2201X- |
Oct-01-2003 |
H |
| DF |
S9M |
H |
|
M |
U |
1 |
F |
$12.67 |
PG |
|
------- |
Oct-01-2003 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$13.37 |
PG |
|
9L----- |
Jan-01-2004 |
H |
| DS |
S9M |
H |
|
M |
U |
1 |
D |
$12.67 |
PG |
|
------- |
Oct-01-2003 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
N |
DISPOSAL |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DS |
R |
REFER TO EDI ITEM |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
INSULIN HUMAN ISOPHANE SUSPENSION AND INSULIN HUMAN INJECTION 5S |
| TEXT |
GENERAL CHARACTERISTICS ITEM DESCRIPTION |
RECOMBINANT DNA ORIGION (YEAST),100 UNITS PER ML; PENFILL CARTRIDGE; 1.5ML; CONTAINS 70 % INSULIN HUMAN ISOPHANE AND 30 % INSULIN HUMAN REGULAR; CARTRIDGE COMPATIBLE WITH INJECTOR,INSULIN,DEVICE,6515-01-345-2263 AND NEEDLE,HYPODERMIC,6515-01-345-2262; THERAPEUTICALLY EQUIVALENT TO NOVO NORDISK; UNIT PKG QTY: 5 |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| DKX1 |
|
Jan-17-2004 |
3 |
H |
|
|
|
|
|